Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1320010.RA6fUbVaOUPFKtnkO_kV5Invb2Czj55Q9Fpzbu53w_wWs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1320010.RA6fUbVaOUPFKtnkO_kV5Invb2Czj55Q9Fpzbu53w_wWs130_assertion type Assertion NP1320010.RA6fUbVaOUPFKtnkO_kV5Invb2Czj55Q9Fpzbu53w_wWs130_head.
- NP1320010.RA6fUbVaOUPFKtnkO_kV5Invb2Czj55Q9Fpzbu53w_wWs130_assertion description "[In order to understand the mechanism underlying multidrug resistance in bladder cancer, we established three doxorubicin-resistant cell lines, T24/ADM-1, T24/ADM-2 and KK47/ADM, and one vincristine-resistant cell line, T24/VCR, from human bladder cancer T24 and KK47 cells respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1320010.RA6fUbVaOUPFKtnkO_kV5Invb2Czj55Q9Fpzbu53w_wWs130_provenance.
- NP1320010.RA6fUbVaOUPFKtnkO_kV5Invb2Czj55Q9Fpzbu53w_wWs130_assertion evidence source_evidence_literature NP1320010.RA6fUbVaOUPFKtnkO_kV5Invb2Czj55Q9Fpzbu53w_wWs130_provenance.
- NP1320010.RA6fUbVaOUPFKtnkO_kV5Invb2Czj55Q9Fpzbu53w_wWs130_assertion SIO_000772 7734314 NP1320010.RA6fUbVaOUPFKtnkO_kV5Invb2Czj55Q9Fpzbu53w_wWs130_provenance.
- NP1320010.RA6fUbVaOUPFKtnkO_kV5Invb2Czj55Q9Fpzbu53w_wWs130_assertion wasDerivedFrom befree-2016 NP1320010.RA6fUbVaOUPFKtnkO_kV5Invb2Czj55Q9Fpzbu53w_wWs130_provenance.
- NP1320010.RA6fUbVaOUPFKtnkO_kV5Invb2Czj55Q9Fpzbu53w_wWs130_assertion wasGeneratedBy ECO_0000203 NP1320010.RA6fUbVaOUPFKtnkO_kV5Invb2Czj55Q9Fpzbu53w_wWs130_provenance.